Measuring and reporting adverse events in clinical trials of psychological treatments for chronic pain

被引：29
|
作者：
Palermo, Tonya M. [1 ,2 ]
Slack, Katherine [1 ]
Loren, Dorothy [1 ]
Eccleston, Christopher [3 ]
Jamison, Robert N. [4 ,5 ]
机构：
[1] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA
[2] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA
[3] Univ Bath, Ctr Pain Res, Bath, Avon, England
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA
来源：
PAIN | 2020年 / 161卷 / 04期
关键词：
COGNITIVE-BEHAVIORAL THERAPY; FUNCTIONAL ABDOMINAL-PAIN; RANDOMIZED CONTROLLED-TRIAL; LOW-BACK-PAIN; KNEE OSTEOARTHRITIS; PSYCHOTHERAPY; PARENTS; INTERVENTION; FIBROMYALGIA; ADOLESCENTS;
D O I：
10.1097/j.pain.0000000000001772
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Supplemental Digital Content is Available in the Text.
引用
收藏
页码：713 / 717
页数：5
相关论文
共 50 条
  • [21] Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials
    Suh, Koung Jin
    Lee, Ji Yun
    Shin, Dong-Yeop
    Koh, Youngil
    Bang, Soo-Mee
    Yoon, Sung-Soo
    Park, Seonyang
    Kim, Inho
    Lee, Jeong-Ok
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (02) : 229 - 239
  • [22] Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials
    Koung Jin Suh
    Ji Yun Lee
    Dong-Yeop Shin
    Youngil Koh
    Soo-Mee Bang
    Sung-Soo Yoon
    Seonyang Park
    Inho Kim
    Jeong-Ok Lee
    International Journal of Hematology, 2017, 106 : 229 - 239
  • [23] Quality of Methods for Assessing and Reporting Serious Adverse Events in Clinical Trials of Cancer Drugs
    Belknap, S. M.
    Georgopoulos, C. H.
    West, D. P.
    Yarnold, P. R.
    Kelly, W. N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (02) : 231 - 236
  • [24] Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials
    Basch, Ethan
    Dueck, Amylou C.
    Rogak, Lauren J.
    Minasian, Lori M.
    Kelly, William Kevin
    O'Mara, Ann M.
    Denicoff, Andrea M.
    Seisler, Drew
    Atherton, Pamela J.
    Paskett, Electra
    Carey, Lisa
    Dickler, Maura
    Heist, Rebecca S.
    Himelstein, Andrew
    Rugo, Hope S.
    Sikov, William M.
    Socinski, Mark A.
    Venook, Alan P.
    Weckstein, Douglas J.
    Lake, Diana E.
    Biggs, David D.
    Freedman, Rachel A.
    Kuzma, Charles
    Kirshner, Jeffrey J.
    Schrag, Deborah
    JAMA ONCOLOGY, 2017, 3 (08) : 1043 - 1050
  • [25] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
    Edwards, Robert R.
    Dworkin, Robert H.
    Turk, Dennis C.
    Angst, Martin S.
    Dionne, Raymond
    Freeman, Roy
    Hansson, Per
    Haroutounian, Simon
    Arendt-Nielsen, Lars
    Attal, Nadine
    Baron, Ralf
    Brell, Joanna
    Bujanover, Shay
    Burke, Laurie B.
    Carr, Daniel
    Chappell, Amy S.
    Cowan, Penney
    Etropolski, Mila
    Fillingim, Roger B.
    Gewandter, Jennifer S.
    Katz, Nathaniel P.
    Kopecky, Ernest A.
    Markman, John D.
    Nomikos, George
    Porter, Linda
    Rappaport, Bob A.
    Rice, Andrew S. C.
    Scavone, Joseph M.
    Scholz, Joachim
    Simon, Lee S.
    Smith, Shannon M.
    Tobias, Jeffrey
    Tockarshewsky, Tina
    Veasley, Christine
    Versavel, Mark
    Wasan, Ajay D.
    Wen, Warren
    Yarnitsky, David
    PAIN, 2016, 157 (09) : 1851 - 1871
  • [26] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
    Edwards, Robert R.
    Dworkin, Robert H.
    Turk, Dennis C.
    Angst, Martin S.
    Dionne, Raymond
    Freeman, Roy
    Hansson, Per
    Haroutounian, Simon
    Arendt-Nielsen, Lars
    Attal, Nadine
    Baron, Ralf
    Brell, Joanna
    Bujanover, Shay
    Burke, Laurie B.
    Carr, Daniel
    Chappell, Amy S.
    Cowan, Penney
    Etropolski, Mila
    Fillingim, Roger B.
    Gewandter, Jennifer S.
    Katz, Nathaniel P.
    Kopecky, Ernest A.
    Markman, John D.
    Nomikos, George
    Porter, Linda
    Rappaport, Bob A.
    Rice, Andrew S. C.
    Scavone, Joseph M.
    Scholz, Joachim
    Simon, Lee S.
    Smith, Shannon M.
    Tobias, Jeffrey
    Tockarshewsky, Tina
    Veasley, Christine
    Versavel, Mark
    Wasan, Ajay D.
    Wen, Warren
    Yarnitsky, David
    PAIN REPORTS, 2021, 6 (01) : E896
  • [27] A data science approach to drug safety: Semantic and visual mining of adverse drug events from clinical trials of pain treatments
    Lamy, Jean-Baptiste
    1600, Elsevier B.V. (115):
  • [28] A data science approach to drug safety: Semantic and visual mining of adverse drug events from clinical trials of pain treatments
    Lamy, Jean-Baptiste
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2021, 115
  • [29] Clinical trials on adverse events of therapy
    Alonso, Miguel Araujo
    MEDWAVE, 2011, 11 (09):
  • [30] Safety reporting in publications of industry-sponsored clinical trials: Evaluation of adherence to adverse events reporting recommendations
    Patil, Sangita P.
    Patil, Madhavi P.
    Shah, Vatsal
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 : 25 - 26
12345